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Abstract
Major Histocompatibility Complex (MHC) class I molecules enable cytotoxic T lymphocytes to destroy virus-infected or
cancerous cells, thereby preventing disease progression. MHC class I molecules provide a snapshot of the contents of a cell
by binding to protein fragments arising from intracellular protein turnover and presenting these fragments at the cell
surface. Competing fragments (peptides) are selected for cell-surface presentation on the basis of their ability to form a
stable complex with MHC class I, by a process known as peptide optimization. A better understanding of the optimization
process is important for our understanding of immunodominance, the predominance of some T lymphocyte specificities
over others, which can determine the efficacy of an immune response, the danger of immune evasion, and the success of
vaccination strategies. In this paper we present a dynamical systems model of peptide optimization by MHC class I. We
incorporate the chaperone molecule tapasin, which has been shown to enhance peptide optimization to different extents
for different MHC class I alleles. Using a combination of published and novel experimental data to parameterize the model,
we arrive at a relation of peptide filtering, which quantifies peptide optimization as a function of peptide supply and peptide
unbinding rates. From this relation, we find that tapasin enhances peptide unbinding to improve peptide optimization
without significantly delaying the transit of MHC to the cell surface, and differences in peptide optimization across MHC
class I alleles can be explained by allele-specific differences in peptide binding. Importantly, our filtering relation may be
used to dynamically predict the cell surface abundance of any number of competing peptides by MHC class I alleles,
providing a quantitative basis to investigate viral infection or disease at the cellular level. We exemplify this by simulating
optimization of the distribution of peptides derived from Human Immunodeficiency Virus Gag-Pol polyprotein.
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Introduction
MHC class I molecules are encoded within the genetic region
known as the Major Histocompatibility Complex and are present
in all nucleated human cells. MHC class I molecules direct
cytotoxic T lymphocytes (CTL) to destroy virus-infected or
cancerous cells, thereby preventing disease progression [1]. They
provide a snapshot of the internal contents of a cell by binding to
peptides arising from intracellular protein turnover and presenting
these peptides at the cell surface, where the peptide-MHC
complex can be recognized by CTL (Fig. 1). Most cells will
present an array of tens of thousands of different peptides at their
surface, some of which will be unique to virus-infected or
cancerous cells. The efficacy of a CTL response to these peptides
depends to a large extent on the ability of MHC class I molecules
to select only a limited number of the potentially billions of
different peptides that are generated by the hydrolysis of all
intracellular proteins [2]. Peptides are selected for presentation on
the basis of their ability to form a stable complex with MHC class
I, by a process known as peptide optimization. A better understanding
of the optimization of peptides is important for our understanding
of immunodominance [1], the predominance of some CTL specific-
ities over others, which can determine the efficacy of an immune
response, the danger of immune evasion, and the success of
vaccination and immunotherapeutic strategies.
Peptide binding to MHC class I occurs in the endoplasmic
reticulum (ER) and is assisted by multiple cofactors that are
thought to enable the optimization process [3]. The transporter
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associated with antigen processing (TAP) supplies the lumen of the
ER with peptides generated in the cytosol and forms the backbone
of the peptide loading complex (PLC). A number of chaperone
molecules also comprise the PLC, namely calreticulin, calnexin,
ERp57 and importantly tapasin, which bridges the gap between
MHC class I and TAP [4] (Fig. 1). Of these chaperones, only
tapasin is known to influence the extent of peptide optimization, in
such a way as to skew the cell surface cargo towards peptides with
low off-rates [5], and this influence is known to vary across
different MHC class I alleles [6].
While a range of interactions between tapasin and MHC class I
have previously been identified [7,8], the effects of these
interactions on peptide optimization are still not well-understood.
A recent study used computational modeling to distinguish
between different hypotheses of tapasin function within the ER
[9], but the model assumed that only peptides with low off-rates
could egress to the cell-surface, and was therefore unable to
predict the optimization of peptides with different off-rates. As a
result, the model was unable to account for observed effects of
tapasin on peptide optimization, both over time [6] and at steady
state [5].
In this paper we present a dynamical systems model for
predicting MHC class I peptide optimization. We include
interactions with the chaperone molecule tapasin, and propose
a relation of peptide filtering to quantify peptide optimization as a
Figure 1. Basic process of MHC class I antigen presentation. Degradation of cytosolic and nuclear proteins, predominantly by the
proteasome, generates peptides that are actively transported into the lumen of the endoplasmic reticulum (ER). Loading and editing of peptide cargo
on MHC class I is achieved in the peptide loading complex, resulting in loaded MHC class I being released into the Golgi and transported to the cell
surface, where the MHC class I peptide complex is presented to the immune system via the T-cell receptor. Known constituents of the peptide
loading complex such as the transporter for antigen processing (TAP), tapasin, ERp57, calreticulin and MHC heavy-chain together with b2m are shown
explicitly.
doi:10.1371/journal.pcbi.1002144.g001
Author Summary
Major Histocompatibility Complex (MHC) class I molecules
bind to protein fragments (peptides) within the cell and
present these fragments at the cell surface, thus providing
a snapshot of the cell contents that can subsequently be
used to trigger an immune response. Only a fraction of the
potentially billions of peptides inside a cell are selected for
presentation, and the process is optimized to select for
peptides that form a stable complex with MHC class I. The
mechanisms of the optimization process are important for
predicting the efficacy of an immune response and for
designing effective vaccines, yet are still not well-
understood. In this article we present a dynamical systems
model of peptide optimization by MHC class I. We show
that peptide optimization can be quantified and mecha-
nistically explained by a peptide filtering relation, which
relates cell surface abundance to peptide supply, peptide
unbinding and interactions with the chaperone molecule
tapasin. The filtering relation also accounts for differences
in optimization across MHC class I alleles. Finally, we show
how the filtering relation can be used to quantify the cell-
surface presentation of virus-derived peptides for immune
system surveillance.
Quantifying MHC Class I Peptide Optimization
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function of peptide supply and peptide off-rates. Using a
combination of published and novel experimental data, together
with a combination of Bayesian inference and kinetic analysis, we
show that tapasin can improve both the rate and extent of peptide
optimization by accelerating peptide off-rate, and that differences
in optimization across MHC class I alleles can be explained by an
allele-specific peptide on-rate. Our filtering relation provides a
mechanistic interpretation for recent experimental observations of
peptide optimization both over time [6] and at steady state [5].
Finally, we demonstrate how the filtering relation can be used to
quantify optimization of a large set of competing peptides in the
context of an immune response, by simulating the cell surface
abundance of Human Immunodeficiency Virus (HIV) peptides in
complex with different MHC class I alleles.
Results
A model of MHC class I peptide optimization
We formulated a dynamical systems model of MHC class I
peptide optimization using a biological modeling language (SPiM
[10], Fig. S1 in Text S1) and exported the model to an equivalent
set of biochemical reactions for further analysis (Fig. 2). The model
characterizes the interactions between MHC, peptides and tapasin
within the endoplasmic reticulum, together with the dynamics of
egressed peptide-MHC complexes at the cell surface.
A number of simplifying assumptions were made when
constructing the model: (i) Peptides Pi are supplied to the ER
at rate gi and then degraded or removed from the ER at rate dP.
Since different peptides Pi can have different levels of abundance
within the cytoplasm and different rates of TAP transport, each
peptide is associated with its own generation rate gi. (ii) MHC
class I heavy chain and b2m are assumed to represent a single
unit, where b2m dissociation from empty class I heavy chain is
interpreted as a form of MHC degradation. (iii) All peptides are
assumed to have a similar rate of binding b to MHC, such that
peptide affinity is determined by a peptide-specific rate of unbinding
ui, and is defined as 1=ui. This is motivated by the measurements
in [11]. (iv) Since MHC, tapasin and peptide continually cycle
between the ER and Golgi apparatus [12,13], we do not explicitly
represent the Golgi as a separate compartment. Instead, we
consider our ER compartment to include both the ER and Golgi,
where the rate of egress e represents the rate of transit from the
Golgi to the cell surface. By representing this process as a first-
order reaction, we are making the simplifying assumption that the
quantity of peptide-MHC complexes which egress is related to
the quantity of complexes in the ER. (v) MHC can load peptides
in the presence of tapasin at a higher rate c, which implicitly
models the stabilization of TAP molecules by tapasin, but we
neglect egress of tapasin-bound MHC, since tapasin retains
MHC by bridging it to the TAP transporter [14]. (vi) Tapasin can
increase the rate of peptide unbinding from MHC by a factor q
[8], while peptide can increase the rate of tapasin unbinding from
MHC by a factor v [15]. Tapasin has been shown to increase the
peptide off-rate to a similar extent for peptides with a range of
off-rates, though some variation has been shown for certain
classes of peptide [8]. (vii) We neglect egress of empty MHC,
which is retained and recycled in the ER by the chaperone
calreticulin [16,17]. (viii) Furthermore, we assume that b2m
dissociation from peptide-loaded or tapasin-bound class I heavy
chain is negligible compared to b2m dissociation from empty class
I heavy chain. (ix) Once at the cell-surface, peptide unbinds from
MHC irreversibly at rate ui, and empty MHC is degraded at rate
dMe. These assumptions can be refined in future iterations of the
model.
Predicting peptide optimization over time
MHC class I HLA-B alleles were previously shown to differ in
their ability to optimize their peptide cargo over time, both in the
presence and absence of tapasin [6]. Specifically, the HLA-B4402
(B4402) allele was shown to be highly dependent on tapasin for
peptide optimization, while the HLA-B2705 (B2705) and HLA-
B4405 (B4405) alleles were shown to be less tapasin-dependent.
B2705 is of particular interest because it is a susceptibility factor
for certain autoimmune diseases and is associated with long-term
non-progression of HIV [18]. Therefore, we sought to use our
peptide optimization model to explain the variation in tapasin-
dependence between HLA-B alleles, through a combination of
model simulation and Information Theory.
We simulated pulse-chase experiments [6] using the peptide
optimization model of Fig. 2 , with representative peptides of low,
medium and high affinity (Text S1). The experiments followed the
thermostability of fixed cohorts of MHC class I complexes over
time, making use of the known correlation between the
thermostability of complexes and the affinity of their peptide
cargo. Specifically, complexes stable at 500C were shown to
contain only high affinity peptides, complexes stable at 370C were
shown to contain a combination of medium and high affinity
peptides, while all complexes were shown to be stable at 40C,
including empty MHC. Since the measurements correspond to
both ER-localized and egressed peptide-MHC complexes, our
assessment of the model was performed by comparing total
peptide-MHC complexes with the 40C measurement, total
medium and high affinity complexes with the 370C measurements,
and total high affinity complexes with the 500C measurements.
Since many of the kinetic parameters of the model have not
previously been measured directly, due to the technical difficulties
involved in obtaining such measurements, we used heuristic search
methods to infer the parameter values from the experimental data
[6] (see Methods). Essentially, this involved finding values for the
parameters which minimized the deviation between the experi-
mental data and the corresponding model simulation. Using this
approach, we investigated how allelic variation in HLA-B might
affect peptide optimization, by distinguishing between allele
parameters, which were allowed to vary between alleles, and fixed
parameters, which were assumed to be invariant between alleles.
Each hypothesized set of allele parameters defined a variant of the
model, which possessed a different intrinsic ability to reproduce
the observed dynamics.
The Bayesian Information Criterion (BIC) [19] was used to
quantify the performance of each set of allele parameters
(equation (18) in Methods). BIC incorporates a term which
penalizes the deviation of the simulation from the data, and a
second term which penalizes increasing numbers of allele
parameters. Therefore, BIC can be used to assess a range of
models by taking into account the added cost of additional
unconstrained variables. Since the dynamics of peptide optimi-
zation varied considerably between HLA–B alleles in the absence
of tapasin [6], we reasoned that at least one allele parameter must
be tapasin-independent. To incorporate this insight whilst
focusing on the principal contributors to allelic variation, we
examined combinations of up to two allele parameters, with at
least one tapasin-independent parameter selected from b, dM ,
dMe, e, gi and ui.The best BIC scores were obtained when the
peptide on-rate b was the only allele parameter (470.38), and
when both b and the rate of egress e were the allele parameters
(469.39; Fig. 3), suggesting that at least peptide on-rate is allele-
specific. However, having both b and e as allele parameters
required unrealistically fast egress of B2705 and B4405 complexes
to obtain a closer fit to the data (Fig. S2 in Text S1). Therefore a
Quantifying MHC Class I Peptide Optimization
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Figure 2. Indexed reactions for a dynamical systems model of MHC class I peptide optimization. Each shape in the model represents a
molecular species and each box represents a reaction, where inbound edges represent reactants and outbound edges represent products. Boxes are
labeled with corresponding reaction rates, where a single rate denotes an irreversible reaction and two rates denote a reversible reaction, with the
rate of the forward reaction indicated on top. The subset of reactions taking place at the cell surface is given byMePi ?ui{ Me ?dMe{ 1 (see Methods
for the full reaction set).
doi:10.1371/journal.pcbi.1002144.g002
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single allele parameter (Fig. 4) b was used, which was able to
effectively account for the experimental data [6]. Specifically, in
the absence of tapasin B4402 exhibited worse time-dependent
optimization than both B2705 and B4405 (Fig. 4 A), while in the
presence of tapasin B4402 exhibited better time-dependent
optimization than both of these alleles (Fig. 4 B). To ensure that
the MCMC search algorithm was robust to random variations,
and could reproducibly generate consistent parameter estimates,
we produced 10 different chains for each model hypothesis. For
the allele-specific b model, 8 out of 10 chains converged to BIC
values between 470.38 and 470.69, while the other two chains
performed poorly. We next plotted the mean and standard
deviation of the posterior distributions of the model parameters
for each of the 10 chains, which revealed that the 8 high
performing chains had overlapping posterior distributions (Fig.
S3 in Text S1), and were therefore producing consistent
parameter estimates.
To understand the effects of an allele-specific peptide on-rate on
peptide optimization, we plotted MHC complexes with high,
medium, and low affinity peptide separately, and distinguished
free and tapasin-bound MHC complexes within the ER and at the
cell surface (Fig. S4 in Text S1). For B4402 without tapasin, an
intrinsically low peptide on-rate meant that the majority of B4402
complexes remained in the ER without peptide, resulting in very
low optimization. For B2705 and B4405 without tapasin, an
intrinsically high peptide on-rate meant that these alleles rapidly
bound their peptide cargo and exhibited good time-dependent
optimization. In contrast, for B4402 with tapasin, most complexes
first bound to tapasin and were subsequently able to rapidly bind
peptides and optimize their peptide cargo, presenting almost
exclusively high affinity peptides at the cell surface. For B2705 and
B4405 with tapasin, the intrinsically high peptide on-rate meant
that peptide out-competed tapasin for binding to MHC, such that
a higher proportion of peptides followed the non-tapasin pathway,
Figure 3. Selection of HLA–B allele parameters. The horizontal axis indicates the set of parameters that were allowed to vary between alleles.
The vertical axis quantifies the Bayesian information criterion (BIC) of the best parameter values for a given set of allele parameters. BIC penalizes
deviations of the model simulation from the experimental data, whilst also penalizing models with more variable parameters, implying that low BIC
values correspond to more representative models. The best parameter values for a given set of allele parameters were inferred using the Filzbach
MCMC software (see Methods).
doi:10.1371/journal.pcbi.1002144.g003
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resulting in reduced optimization. Thus, variation in the intrinsic
ability of free HLA–B alleles to bind peptide in the absence of
tapasin was shown to be the most likely explanation for allelic
variation in peptide optimization, both in the presence and
absence of tapasin. For all three alleles, cell surface optimization
could not be improved by modifying most other parameters in the
model (c, uT , v, q and e) (Fig. S5 in Text S1). This indicates that
the balance between peptide binding b and tapasin binding bT is a
major determinant of peptide optimization, achieved by control-
ling the effectiveness of the tapasin-mediated pathway. The
prediction that allele-specific tapasin dependency results from
variations in peptide binding to MHC class I molecules is
consistent with analysis from molecular dynamics simulations,
which suggest that tapasin stabilizes peptide-receptive conforma-
tions [20]. This stabilization in the presence of tapasin is
represented in our model by setting the binding rate c to be
allele-independent and greater than or equal to the binding rate b.
In the absence of tapasin, MHC class I molecules of different
alleles may have varying levels of peptide receptiveness, which is
represented in our model by allowing b to vary between alleles.
Figure 4. Simulation of time-dependent peptide optimization by HLA–B. The peptide optimization model of Fig. 2 was used to simulate a
labeled cohort of peptide-MHC complexes by switching from generation of an unlabeled MHC population to a labeled population for 5 min (yellow
blocks). The plots represent the concentration of total labeled MHC (blue), labeled MHC with medium or high affinity peptide (green) and labeled
MHC with high affinity peptide only (red), at each time point. Simulations were performed in the absence (A) and presence (B) of tapasin.
Corresponding experimental results [6] are also reported (circles). Simulations were conducted for representative low, medium and high affinity
peptides with a separate dissociation rate ui and generation rate gi for each peptide Pi , and a separate peptide binding rate bj for each HLA–B allele
Mj (Table S1 in Text S1; Protocol S1).
doi:10.1371/journal.pcbi.1002144.g004
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Kinetic control of peptide optimization
Having established a hypothesis which explains how MHC
alleles experience differential tapasin-dependence, we sought to
identify the mechanisms that determine the extent and rate of
peptide optimization, both in the presence and absence of
tapasin. Peptide optimization is the process by which high affinity
peptides are selected for presentation at the cell surface [6].
Peptide-MHC complexes generally need to be stable for many
hours or days at the cell surface in order to effectively elicit an
immune response [21], yet peptide optimization in the ER is
typically limited to tens of minutes [3,6,22]. This requires
optimization beyond the limit that would be obtained in
equilibrium. How such high optimization is achieved in so little
time is still not well-understood [3].
One way to increase the extent of peptide optimization is for
peptide-MHC complexes to be retained in the ER for an extended
period prior to egress, so that unstable peptides have an
opportunity to unbind [22]. However, delaying egress also
increases the time for complexes to reach the cell surface.
Therefore, a trade-off exists between the extent of optimization
and the rate at which this optimization can be achieved. We
quantify this trade-off by calculating the relative probabilities of
MHC egress and peptide unbinding.
Consider an MHC complex containing a peptide with off-rate
ui (Fig. 5 A). The complex can either egress to the cell surface at
rate e, or the peptide can unbind at rate ui. The probability of
each event is proportional to its rate, such that the probability of
egress is given by e= uizeð Þ. The competition between unbinding
ui and egress e defines a peptide filtering step, where the basic
filtering mechanism is comparable to principles of kinetic proof-
reading [23]. Let MePi½  denote the expected number of peptide-
MHC complexes that egress to the cell surface before the peptide
Figure 5. Filtering relation of MHC class I peptide optimization. (A) Consider a population ofNi MHC complexes containing peptides with off-
rate ui . ½MePi denotes the expected number of MHC complexes that will egress before the peptide can escape. O(MePi) denotes the expected
proportion of egressed MHC complexes that will contain peptides with off-rate ui . This defines a measure of peptide optimization. We plot ½MePi  and
O MePið Þ as functions of e for three peptides with different off-rates and the same initial populations. Maximal optimization is achieved when e%ui , with
MePi½ &Ni e
ui
(dashed lines). (B) Consider a population ofNi tapasin-MHC complexes containing peptides with off-rate ui . ½MePi denotes the expected
number of MHC complexes that will unbind from tapasin and egress before the peptide can escape, where x~uTv=q.O(MePi) is defined as in A. We plot
½MePi  and O(MePi) as functions of x with e~10{5 (black line in A). Maximal optimization is achieved when e,x%ui , with ½MePi&Ni ex
u2i
.
doi:10.1371/journal.pcbi.1002144.g005
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can escape (Fig. 5 A). If there are Ni MHC complexes containing
peptides with off-rate ui in the ER, we expect Nie= uizeð Þ to
egress and the remainder to release their peptide cargo. For very
high e, all Ni complexes will egress irrespective of their peptide
cargo. For very low e, the number of egressed complexes will tend
to Nie=ui. Let O MePið Þ denote the proportion of egressed MHC
complexes containing peptides with off-rate ui (Fig. 5 A). This
defines a measure of peptide optimization. For very high egress we
observe no optimization, where the proportion of peptides at the
cell surface is equal to the proportion of peptides in the ER. For
very low egress we observe maximum optimization, where the
proportion of peptides at the cell surface varies inversely with the
peptide off-rate.
The introduction of tapasin provides an additional filtering step
(Fig. 5 B), involving a competition between peptide unbinding uiq
and tapasin unbinding uTv. Let ½MePi denote the expected
number of MHC complexes that unbind from tapasin and egress to
the cell surface before the peptide can escape (Fig. 5 B). For very
high e and x~uTv=q, all Ni complexes will egress irrespective of
their peptide cargo. For very low e and x, the number of egressed
peptide-MHC complexes will tend to Niex=u
2
i . The number of
egressed complexes therefore varies with 1=u2i in the presence of
tapasin (Fig. 5 B), compared with 1=ui in the absence of tapasin
(Fig. 5 A). This implies that tapasin enhances presentation
according to peptide affinity 1=ui, in agreement with experimental
results [5]. Since the proportion of egressed complexes now varies
inversely with the square of peptide off-rate, low affinity peptides
are much more likely to escape than high affinity peptides,
resulting in improved peptide optimization.
The peptide filtering relation presented above also holds for the
full dynamical systems model of Fig. 2 , in which peptides can bind
and unbind multiple times to MHC. By translating the reactions of
Fig. 2 to a set of ordinary differential equations, we obtained the
following expression for the steady-state concentration of peptide-
MHC complexes at the cell surface (see Methods):
½MePi~ 1
ui
e
uize
(b½Mz x
uizx
c½TM)½Pi ð1Þ
where x~uTv=q. The equation includes the ER peptide filtering
steps described in Fig. 5, together with peptide optimization at the
cell surface given by 1=ui, where peptides with a lower off-rate ui are
more likely to remain bound to MHC. The equation also quantifies
the ratio of egressed peptide-MHC complexes that are loaded in the
presence and absence of tapasin, given by the ratio of
½TMcx=(uizx) to b½M. Assuming peptide loading takes place
via the tapasin pathway (½TM&½M) and that peptides have a
high turnover in the ER [24], characterized by high generation and
degradation rates (½Pi&gi=dP), we can simplify equation (1) as
½MePi&C gi
x
uizx
e
uize
1
ui
Supply Tapasin ER Surface
ð2Þ
where C~c½TM=dP. This corresponds to an upper bound on
peptide optimization in the presence of tapasin. In the absence of
tapasin, the equation for ½MePi is the same as (2) but without
the tapasin optimization step x=(uizx). This implies that tapasin
enhances peptide presentation according to peptide affinity 1=ui,
in agreement with the analysis of Fig. 5 and experimental
findings [5].
To further place our insights in a biological context, we used the
dynamical systems model to identify the mechanisms that
determine the rate of peptide optimization. Consider the filtering
step between peptide unbinding uiq and tapasin unbinding uTv.
Tapasin can enhance peptide optimization to the same extent
either by increasing the peptide off-rate by a given factor q, or by
decreasing the tapasin unbinding rate by the same factor.
However, decreasing the tapasin unbinding rate essentially delays
the transit of MHC to the cell surface, resulting in slower
optimization. In contrast, increasing the peptide off-rate allows
tapasin to increase the extent of peptide optimization while still
maintaining a rapid flux of peptide-MHC complexes to the cell
surface.
Predicting peptide optimization at steady-state
To further probe the applicability of our model, we investigated
whether it could be used to predict peptide optimization at steady
state. Previously, the effects of tapasin on steady-state peptide
optimization were measured for peptides in the MHC class I allele
H22Kb (Kb) [5]. The experiments were conducted using four
target peptides, obtained by performing substitutions at positions 5
and 8 of the amino acid sequence SIINFEKL. Peptide off-rates
were measured in RMA-S cells and each of the target peptides
were introduced as minigenes into a tapasin-deficient cell line
(.220) and into the same cell line transfected with tapasin
(.220.Tpn). Steady-state levels of cell surface peptide-MHC
complexes were measured by flow cytometry using mAb 25.D1
(Fig. 6 C, Table S3 in Text S1), which specifically recognizes the
SIINFEKL peptide variants bound to Kb [25]. Total cell-surface
MHC was also measured with mAb Y3, which recognizes empty
and peptide-occupied Kb (Fig. 6 D, Table S3 in Text S1).
We complemented previous experimentation [5] by measuring
the off-rates of the target peptides in .220 cells directly. Cells were
treated with Brefeldin A (BFA) to prevent further MHC egress,
allowing direct characterization of the dissociation of cell-surface
MHC complexes carrying SIINFEKL peptide variants with
25.D1. The off-rates of the target peptides were estimated by
fitting single exponential decays (SIINFEKL: 1:44|10{5s{1,
SIINFEKV: 1:97|10{5s{1, SIINFEKM: 2:49|10{5s{1, SII-
NYEKL: 1:53|10{4s{1; Fig. 6 A). We also used Y3 to measure
total MHC during BFA incubation of cells with no target peptide,
in the presence and absence of tapasin, to provide an indication of
the off-rates of endogenous peptides presented by .220 and
.220.Tpn cells (Fig. 6 B).
We simulated the above experiments using the peptide
optimization model of Fig. 2 with a parameter set specific to
H22Kb (Table S2 and Fig. S6 in Text S1). The full range of
endogenous peptides was characterized by two representative
peptides with off-rates u1 and u2, and supply rates g1 and g2 (Text
S1). Each experiment was simulated using one of the target
peptides with off-rate ui, together with the representative
endogenous peptides. Since target peptides were expressed at
approximately equal levels inside cells [5], we assumed that they
were generated at the same rate gi~g0. The model simulations
agreed with the trends observed experimentally, accurately
recapitulating the enhancement of steady state optimization
conferred by tapasin (Fig. 6 C, D, Table S3 in Text S1). However,
we observed that the model did not fit the experimental data for
SIINFEKM as well as for the other target peptides. We
hypothesized that the poor fit could be caused by increased
TAP transport of the SIINFEKM peptide, due to a change in the
terminal residue at position 8 [26]. To explore this idea, we
increased the generation rate of SIINFEKM by a factor of 2.5,
which gave a better fit to the experimental results (Fig. 6 D). This
Quantifying MHC Class I Peptide Optimization
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Figure 6. Peptide optimization and trafficking for H22K.b The model of Fig. 2 was calibrated for H22Kb by varying the rates of peptide
binding, MHC degradation at the cell surface, and egress (Table S2 in Text S1; Protocol S2). Each simulation computes the steady state of the model
with three types of peptide: two background peptides P1 and P2 and one of the four SIINFEKL peptide variants Pi (ui estimated from data in panel A).
(A) Release of peptides from MHC following treatment with brefeldin A (BFA) measured with 25.D1 (symbols), fitted to single exponential decays
(solid lines). (B) Dissociation of endogenous peptides from cells treated with BFA. (C) Steady-state presentation of specific peptide-MHC complexes at
the cell surface, comparing simulation with measurements of 25.D1 from [5]. (D) Total steady-state peptide-MHC complexes (cell surface), comparing
simulation with measurements of Y3 from [5]. Simulated values were scaled by a proportionality factor for optimally overlapping the 25.D1 data (with
SIINFEKM removed) and the Y3 data (all points) (Text S1). (B–D) The x-axis shows the relative affinity of peptides given by the inverse of the off-rate.
Steady state concentrations were obtained by equating the right hand sides of the ODEs to zero. Steady state concentrations in tapasin-deficient cells
were simulated by setting gT~0. (E–G) For quantifying egression of peptide-MHC complexes, .220.K
b (E) and .220.Kb .Tpn (F) were pulsed for 10 min
with 35S-Met/Cys and chased for the indicated times (min). Y3 immunoprecipitates were digested with endoglycosidase-H (EndoH) and SDS-PAGE
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hypothesis further highlights the potential importance of peptide
supply in predicting relative presentation levels [27], as can be
seen from the peptide filtering relation (2). Although experimental
measurements were only obtained for four distinct peptides, the
model predicts the presentation levels for a continuum of peptide
off-rates over a broad range, which can be checked in future
experiments.
To distinguish between optimization resulting from delayed
tapasin unbinding versus enhanced peptide off-rate, we measured
the time taken for a fixed cohort of pulse-labeled MHC complexes
to reach the cell surface by measuring endoglycosidase-H (EndoH)
resistance (Fig. 6 E–G). By taking into account the temporal
constraints of the EndoH data, we found that enhanced peptide
off-rates were required to allow increased peptide optimization in
the presence of tapasin without significantly delaying the transit of
peptide-MHC complexes to the cell surface (see Fig. S7 in Text
S1). Further parameter variation analysis indicated that cell
surface optimization is nearly maximal in the H22Kb model with
respect to q, uT , v and c, but could be improved by reducing e (Fig.
S8 in Text S1). However, reducing e decreases the export of
peptide-MHC complexes, suggesting a possible trade-off between
optimization and the efflux of new information concerning cellular
protein content.
Predicting optimization of viral peptides
To illustrate how the peptide optimization model may be used
in more realistic scenarios, we simulated the presentation of HIV-
derived peptides using our models for the HIV-associated allele
HLA–B2705 (B2705), and HLA–B4402 (B4402) for comparison.
Peptides between 8 and 10 amino acids in length were identified
from the Gag-Pol polyprotein (UniProt; accession P03367) and
assessed for their off-rates using the BIMAS prediction algorithm
[28]. For B2705, the slowest off-rate identified was for the
immunodominant KRWIILGLNK (positions 262–272) epitope
[29] (off-rate: 3:8508|10{7s{1). For B4402, the allele parame-
ters of the BIMAS algorithm were not available, so we quantified
off-rates based on the BIMAS algorithm parameters for the closely
related allele B4403. The off-rates identified were generally higher
than for B2705 (Fig. 7 A). When comparing simulations of B4402
in the presence and absence of tapasin, the highest affinity peptide
AETGQETAY (positions 1250–1258; off-rate: 2:1393|10{5s{1)
was enhanced by a factor of 445 by tapasin (Fig. 7 B), though cell
surface presentation was over 25 times less than the presentation of
KRWIILGLNK by B2705 (Fig. 7 B). Despite B2705 being a
relatively tapasin-independent allele [6] (Fig. 4), tapasin signifi-
cantly enhanced presentation of peptide KRWIILGLNK by a
factor of 120 (Fig. 7 C).
and autoradiography were performed. Arrows indicate Kb heavy chain resistant (R) and sensitive (S) to EndoH digestion. EndoH analysis of H22Kb
was performed as described previously [6]. (B–D, G) The solid lines indicate model simulations and triangles indicate measured data-points. The
experimental data for (A,B,E–F) is novel, while the experimental data for (C,D) is from [5].
doi:10.1371/journal.pcbi.1002144.g006
Figure 7. Simulation of cell surface presentation of HIV virus peptides by HLA–B2705. The sequence of the HIV-1 polyprotein Gag-Pol was
obtained from the UniProt online resource (accession P03367). All peptides between 8 and 10 amino acids in length were then derived from the
sequence and assessed for their off-rates using the BIMAS prediction algorithm (http://www-bimas.cit.nih.gov/molbio/hla_bind [28]). The peptides
were then simulated by assuming that they are all supplied into the ER via TAP at an equal rate, such that the total supply rate is equal to the total
supply rate estimated for Fig. 4. As the algorithm predicted many peptides to have the same off-rate, peptides were clustered for ease of
computation. (A) The number of peptides with a given peptide off-rate, as calculated by BIMAS. (B) Steady-state cell surface presentation of peptide-
MHC complexes as a function of peptide off-rate. Peptide supply was assumed to be constant for each individual peptide. Therefore, the supply rate
associated with a particular off-rate is simply scaled by the number of peptides with that off-rate, as quantified in A. The lowest off-rate (highest
affinity) peptides for B2705 (KRWIILGLNK) and B4403 (AETQCETAY) are indicated. Simulations were performed for the presence and absence of
tapasin, as indicated in the key. (C) Enhancement of cell surface presentation by tapasin was computed by dividing simulated tapasin-sufficient
presentation by simulated tapasin-deficient presentation for each peptide. The results of the HIV simulations illustrate the extent to which tapasin
can affect a downstream immune response. Theoretically, tapasin can enhance presentation by up to a factor 1=u, where u is the off-rate of the
peptide from MHC (Fig. 5). However, the characteristics of the MHC allele, such as the allele-specific peptide on-rate, can significantly alter the effect
of tapasin on the presentation of a given peptide. Our model allows differences in presentation levels to be quantified by taking into account peptide
supply and peptide off-rate, together with the effects of tapasin and the binding properties of the MHC class I allele under consideration. In particular,
our analysis of the HIV-1 Gag-Pol polyprotein provides a specific quantitative prediction for the cell surface presentation of the immunodominant
KRWIILGLNK by HLA–B2705. By simulating the range of peptides derived from Gag-Pol, representing a range of off-rates, we observe that the
enhancement by tapasin is independent of peptide supply, instead being wholly determined by the peptide off- and on-rates (Fig. 7 C).
doi:10.1371/journal.pcbi.1002144.g007
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Discussion
The optimization of peptide-MHC class I complexes at the
surface of antigen presenting cells is one of the key factors that
determines the hierarchy of the T-cell response to a complex
antigen [1]. Peptide optimization is also important for vaccine
design, where vaccine peptides compete with endogenous peptides
for presentation [1,30]. In this paper we propose a dynamical
systems model of MHC class I peptide optimization, which takes
into account the supply of peptides in the cytosol, the affinity of
peptides to MHC and the interactions between peptide and MHC
at the different stages of the optimization process, both within the
ER and at the cell surface. The model also incorporates the effects
of tapasin, which is known to increase peptide optimization [5]
and to affect different MHC class I alleles to different extents [6].
This variation in tapasin dependence may protect from viral
immune evasion strategies such as tapasin inhibition by an
adenovirus [31].
The dynamical systems model is firmly grounded in experi-
mental data, and techniques already exist to measure many of the
model parameters [5–8]. The model therefore allows a multitude
of experimental results to be unified within a common framework,
so that a range of mechanistic hypotheses can be formulated and
tested. We derive a peptide filtering relation which, for the first
time, provides a mechanistic explanation for experimental data on
MHC class I peptide optimization, both over time [6] and at
steady state [5]. Specifically, it suggests that tapasin enhances
peptide off-rate in order to improve peptide optimization without
significantly delaying the transit of MHC to the cell surface.
We have also shown that an allele-specific peptide on-rate is the
most likely mechanistic explanation for differences in peptide
optimization across HLA–B alleles. A possible interpretation is
that differences in peptide on-rate are due to allelic differences in
molecular conformation. For example, alleles such as B4402 could
adopt a closed conformation, reducing the ability of peptides to
bind MHC, while alleles such as B2705 could adopt a more open
conformation, allowing peptides to readily bind MHC, as
suggested in [32]. When tapasin binds to MHC the peptide
binding groove may then adopt a peptide receptive conformation,
allowing MHC to bind peptides more readily, as suggested in [20].
Although allelic differences in the conformation of MHC class I
are largely peptide-independent, variations in the on-rates of
different peptides have nevertheless been observed. These
variations can be incorporated in future versions of the model
by allowing a separate on-rate for each peptide. However,
published estimates indicate that variations in the affinity of
peptide-MHC interactions are mostly governed by variations in
peptide off-rate [11], supporting our assumption that the on-rate is
allele-specific and largely peptide-independent.
Although the current model makes a number of simplifying
assumptions on the antigen presentation process, the model can be
readily extended to incorporate additional details as more data are
acquired. These details could include the explicit contribution of
TAP transport, proteasomal cleavage and cytosolic protein
abundance to ER peptide supply [26,33,34]. At present these
mechanisms are only implicitly represented in the model via
peptide-specific supply rates gi. Further extensions could also
include conformational changes in MHC [7], and chaperones
such as ERp57 and calreticulin which are known to influence total
cell-surface presentation [15,17]. Since the mechanisms by which
additional chaperones interact with MHC class I are only partially
known, we can investigate a variety of hypotheses by using our
Information Theoretic framework to assess allele-specific chaper-
one-dependency. In the future, coupling model analysis with
additional experimental measurements will enable quantitative
predictions of peptide optimization for a wide range of MHC class
I genotypes. Having a robust model, known to make accurate
predictions, will improve our ability to assess the efficacy of
vaccines involving multiple peptides, and will provide a quanti-
tative means to prioritize different vaccination strategies.
The current work is part of a broader research programme to
use experimental data to build credible mathematical models of
immunological processes, ranging from relatively simple examples
to complex systems such as organ-specific autoimmunity. The
resulting models can then be used to make specific and testable
predictions that relate directly to immunological function.
Subsequent iterations offer an opportunity to refine or develop
the models from the simple to the complex, or from the static to
the time-resolved, at the molecular, cellular or organ level.
Methods
Ordinary differential equation representation of the
dynamical systems model
The chemical reaction representation of the dynamical systems
model of Fig. 2 is as follows:
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By assuming mass-action kinetics, we converted the system of
reactions to a set of ordinary differential equations (ODEs), where
½X  denotes the concentration of a given species X and ½X 0
denotes rate of change in concentration.
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The dependent variables consist of MHC (M), peptide (Pi),
tapasin (T), egressed MHC (Me) and the complexes formed
between these elements. The equations denote a two-compart-
ment system, comprising an ER model (3)–(8) and a cell surface
model (9)–(10).
Steady-state analysis of the ODE representation
Equation (1) was derived by considering the steady state
(equilibrium) solutions of the ODE representation. By equating
½MPi0, ½TMPi0 and ½MePi0 with zero, we obtained the following
expressions for ½TMPi and ½MPi:
½TMPi~ (uize)½MPi

{b½M½Pi
uTv
~
c½TM½Pi
uiqzuTv
ð11Þ
½MPi~ ui½MePi

e
ð12Þ
By substituting (12) in (11) we obtained the expression for the
steady-state concentration of egressed MHC complexes with a
given peptide Pi in equation (1)
½MePi~ 1
ui
e
uize
(b½Mz x
uizx
c½TM)½Pi
where x~uTv=q. The equation incorporates the peptide filtering
steps described in the main text, where e=(uize) denotes the
optimization of free MHC in the ER, while x=(uizx) denotes the
optimization of MHC bound to tapasin in the ER. For a given
peptide with off-rate ui, the optimization of free and tapasin-bound
MHC is therefore fully determined by e and x, respectively.
Moreover, MHC complexes optimized in the presence of tapasin
will always be subject to an additional optimization step after
tapasin unbinding. The equation also incorporates optimization of
MHC at the cell surface given by 1=ui , where peptides with a
lower off-rate ui are more likely to remain bound to MHC.
Optimizing model parameters with respect to
experimental data
Heuristic search methods were used to fine-tune model
parameters, based on the available experimental data. Our
approach was to minimize a cost function, defined as the sum of
the squared differences between experimental data y
(i)
d (i~1,n)
and corresponding model simulated output y(i)m , subject to an
arbitrary proportionality constant a. i.e.
min
p[P
D(p) ð13Þ
where D(p)~min
a[R
Xn
i~1
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d {ay
(i)
m )
2
y
(i)
d
( )
ð14Þ
where P is the space of search parameters, which may be the full
parameter set or a subset thereof. For the inner minimization
problem (14), it is possible to assign an optimal a~a(=0), by
equating the partial derivative of D (with respect to a) to 0.
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Approximate minimizers of the multi-dimensional objective
function (13) were found using a Metropolis-Hastings (MH)
algorithm.
During execution of the MH algorithm, a Markov chain of
proposal parameter sets is formed. Starting from an initial
parameter set p~p0 with associated objective function value
D(p0)~D0, the algorithm iteratively searches neighboring param-
eter sets by accepting or rejecting new proposal parameter sets at
each step. Neighboring points p^ are proposed with probability
Q(p,p^), according to a jump rule
p^~f (p) ð17Þ
The chain moves to the new point p^ according to an acceptance
criterion, which makes a probabilistic choice about whether to
accept p^. Given an observation u drawn from U(0,1), the proposal
point is accepted providing
uvmin Q(p,p^)P(p^)
Q(p^,p)P(p)
,1
 
where P(p) is the probability that the parameter set p matches the
data and Q(p,p^) is the proposal density (which we fix to be
symmetric). Assuming the deviations from the experimental data
are Gaussian distributed and that D(p) makes only small jumps,
the acceptance ratio is approximately given by
P(p^)
P(p)
&e(D(p){D(p^))
Note that when D(p)wD(p^) we always move to p^, because the
exponential function of a positive number is greater than one. The
algorithm iterates until some termination condition is reached,
such as a maximum number of iterations or a convergence
condition. All parameter searches were performed using ‘Filz-
bach’, a software library for carrying out Metropolis-Hastings
Markov chain Monte Carlo parameter estimation in C++ or C#.
Filzbach is under development in the computational science lab at
Microsoft Research Cambridge and is available for download,
complete with a suite of example uses, via http://research.
microsoft.com/science.
Model selection using the Bayesian Information Criterion
To assess which model parameter(s) should be allele-specific,
different hypotheses were compared using the Bayesian Information
Quantifying MHC Class I Peptide Optimization
PLoS Computational Biology | www.ploscompbiol.org 12 October 2011 | Volume 7 | Issue 10 | e1002144
Criterion (BIC) [19]. The BIC is defined as
BIC~{2 log fk(xDpk)zki log n ð18Þ
where pk is the parameter set associated with model hypothesis k
that maximizes the likelihood function fk, and x~ x1, . . . ,xnf g are
the experimental observations. This is equivalent to minimizing
the residual sum of squares, as in (14). It can be seen from this
equation that the BIC penalizes the introduction of additional
parameters.
Solving the model equations
The model equations (3)–(10) were solved throughout using the
CVODE routine [35], as part of SUNDIALS suite of numerical
integrators [36]. During optimization with Filzbach, simulation
code was written in C and compiled using Microsoft Visual Studio
2010. For plotting the simulations results, we used MATLAB and
the SUNDIALS Toolbox for MATLAB. We have also provided
an implementation of the model in SBML format for HLA–B
(Protocol S1) and H22Kb (Protocol S2).
Computing the equilibrium concentrations
The equilibrium concentrations were computed from the model
equations by equating the right hand sides to zero. This amounts
to solving a system of nonlinear equations f (x)~0, where x is the
vector of concentrations and f describes the fluxes resulting from
production, degradation, binding, unbinding and ER egression.
When using MATLAB, we used an implementation of the
Levenberg-Marquhardt (L–M) search algorithm [37] to find
solutions. When using the C implementation or in the case where
the L–M algorithm did not converge to a non-negative solution,
the ODEs were simulated using CVODE until the solution had
not changed by more than 0.1% over a time interval of 1000
minutes. The latter method guarantees a non-negative solution
providing the initial condition is also non-negative.
Decay of MHC class I from the cell-surface with Brefeldin
A
Brefeldin A (BFA) blocks anterograde traffic from the ER and
thus the Golgi fuses with the ER. This prevents export of any
newly synthesized class I from the ER to the cell-surface [38,39].
BFA (Sigma, UK) was dissolved in methanol at 4 mg/ml for
storage at{200C and used at 5 mg ml{1. 3|105 suspension cells
were plated in 1 ml cell medium in a 24-well plate. 5 mg ml{1
BFA was added for the indicated times and all the cells were
harvested at the same time for flow cytometry. Cells were
harvested for flow cytometry as previously described [5].
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